While we have shown that for the GAB, affinity maturation of the γδTCR is not essential when naturally selected high affinity CDR3 sequences of the δ chain are used (13), we hypothesized that increasing the tumor binding avidity of the Vγ9δ2 TCR would further improve the effectivity of a GAB. Here, A1BG is linked to neoplasm.